Research Article

Isolation and Characterization of NP-POL Nonapeptide for Possible Therapeutic Use in Parkinson’s Disease

Figure 5

The effect of the NP-POL peptide on intracellular ROS generation induced by 6-OHDA. (a) NP-POL significantly reduced intracellular ROS levels in PC12 cells. (b) 6-OHDA induced an exponential increase in intracellular ROS in exposed cells. Both 1 h preincubation (c) with selected doses of NP-POL before 24 h of 6-OHDA exposure and 24 h of coincubation with NP-POL and 6-OHDA (d) resulted in a significant decrease in intracellular ROS levels. Data are expressed as mean ± SD (). Results were considered significant at versus untreated cells and , , and versus 6-OHDA.
(a)
(b)
(c)
(d)